FM
Frazier Management Portfolio holdings
AUM
$1.12M
This Quarter Return
+32.77%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$280M
AUM Growth
+$280M
(+44%)
Cap. Flow
+$25.5M
Cap. Flow
% of AUM
9.1%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$25.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AnaptysBio
ANAB
$569M
| $129M | 45.97% | 3,688,448 | – | – |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $39.2M | 13.98% | 2,600,014 | – | – |
|
|
RXDX
3
DELISTED
Ignyta, Inc.
RXDX
| $26.8M | 9.57% | 2,173,593 | – | – |
|
|
ALPN
4
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $25.5M | 9.1% | +2,199,011 | New | +$25.5M |
|
5
Collegium Pharmaceutical
COLL
$1.22B
| $19.8M | 7.06% | 1,887,332 | – | – |
|
6
Iovance Biotherapeutics
IOVA
$807M
| $17M | 6.05% | 2,188,331 | – | – |
|
|
SRRA
7
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $12.6M | 4.48% | 8,112,121 | – | – |
|
8
Cidara Therapeutics
CDTX
$1.66B
| $10.6M | 3.79% | 1,312,258 | – | – |
|